MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamaophthalmol.2013.1718

Медицинская библиотека · JAMA ophthalmology · 2013

Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.

Ray Kathryn J, Prajna Lalitha, Srinivasan Muthiah, Geetha Manoharan, Karpagam Rajarathinam, Glidden David, Oldenburg Catherine E, Sun Catherine Q, McLeod Stephen D, Acharya Nisha R, Lietman Thomas M

Сравнительное исследованиеСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To analyze the relationship between fluoroquinolone use at presentation and minimum inhibitory concentration in bacterial keratitis.

METHODS

The Steroids for Corneal Ulcers Trial was a randomized, double-masked, placebo-controlled trial assessing the effect of adjunctive topical corticosteroid treatment on outcomes in bacterial keratitis. After presentation, all patients were treated with moxifloxacin hydrochloride, 0.5%. We compare antibiotic use at presentation with minimum inhibitory concentration against moxifloxacin for all isolates. Separate analyses accounted for organism species and fluoroquinolone generation.

RESULTS

Topical fluoroquinolone use at presentation was reported in 92 of 480 cases (19.2%). Causative organisms in the 480 cases included Streptococcus pneumoniae (247 cases [51.5%]), Pseudomonas aeruginosa (109 cases [22.7%]), and Nocardia species (55 cases [11.5%]). Isolates from patients who reported fluoroquinolone use at presentation had a 2.01-fold-higher minimum inhibitory concentration (95% CI, 1.39-fold to 2.91-fold; P < .001). Fourth-generation fluoroquinolones were associated with a 3.48-fold-higher minimum inhibitory concentration than those isolates that were not exposed to pretreatment at enrollment (95% CI, 1.99-fold to 6.06-fold; P < .001).

CONCLUSION

This study provides evidence that prior use of fluoroquinolones is associated with antibiotic resistance.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00324168.

Для цитирования: Ray Kathryn J, Prajna Lalitha, Srinivasan Muthiah, Geetha Manoharan, Karpagam Rajarathinam, Glidden David, Oldenburg Catherine E, Sun Catherine Q, McLeod Stephen D, Acharya Nisha R, Lietman Thomas M. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.. JAMA ophthalmology. 2013. DOI: 10.1001/jamaophthalmol.2013.1718.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.